InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-25)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

SIBAJI BISWAS — personal trades · 15 filings

← Executives ★ Sign in to follow

SB

SIBAJI BISWAS

ININ·SEBI (PIT + SAST)

Syngene International Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the detailed record of transactions filed by SIBAJI BISWAS. Officer active across 1 companies, notably Syngene International Limited. In total, 15 disclosures have been logged. The latest transaction was disclosed on 7 November 2024 — Sale. Regulator: SEBI (PIT + SAST). All data is free.

Declarations15 total

Executives●SaleSSyngene International Limited0SEBI

S

€353,44635,000 shares@ €10.0985

Equity Shares

SEBI:b31bc8310cb179c9401e132dcf0a639ca17eac27·7 Nov 2024

Executives●PurchaseSSyngene International Limited0SEBI

S

€850,17086,431 shares@ €9.8364

Equity Shares

SEBI:7efa8fcd912c6b25f9fdfc553cee345d982d82a9·7 Nov 2024

Ideal exit: 4 Aug 2025 (T+270)

Executives●SaleSSyngene International Limited0SEBI

S

€39,2484,750 shares@ €8.2627

Equity Shares

SEBI:0bcdfc6c329ab20fe7a15b24ba6c4f059fb4860b·30 Nov 2023

Executives●SaleSSyngene International Limited0SEBI

S

€82,08010,000 shares@ €8.208

Equity Shares

SEBI:2a733f487a69e2ab9c473b0f7a3014223243041e·30 Nov 2023

Executives●SaleSSyngene International Limited0SEBI

S

€2,061250 shares@ €8.2432

Equity Shares

SEBI:ebaaf46ce1aa6d7e3ba8bdc1e20ad7ff3683483f·24 Nov 2023

Executives●SaleSSyngene International Limited0SEBI

S

€40,6475,000 shares@ €8.1294

Equity Shares

SEBI:f0dd96acbb5eec6126ca6c5cb33128c4e7738d29·29 Nov 2023

Executives●SaleSSyngene International Limited0SEBI

S

€247,88230,000 shares@ €8.2627

Equity Shares

SEBI:f4ea3cf19b62077c2c8e805d812a5839aebc8d25·28 Nov 2023

Executives●SaleSSyngene International Limited0SEBI

S

€205,15922,569 shares@ €9.0903

Equity Shares

SEBI:4268be01823a8d1c8d11b779435241bfeb8a4d67·29 Sept 2023

Executives●SaleSSyngene International Limited0SEBI

S

€395,73045,000 shares@ €8.794

Equity Shares

SEBI:b94e6b2373eb0ce6708d78d4098e2ddb0be36ebd·27 Sept 2023

Executives●SaleSSyngene International Limited0SEBI

S

€44,3395,000 shares@ €8.8678

Equity Shares

SEBI:4790a428f6d4f74a8b0f08cdee9799eeed13e9e2·28 Sept 2023

Executives●PurchaseSSyngene International Limited0SEBI

S

€364,07750,036 shares@ €7.2763

Equity Shares

SEBI:b2fac2cb7fcecdd5a153074ac5084af762552ad7·16 Aug 2022

Ideal exit: 13 May 2023 (T+270)

Executives●PurchaseSSyngene International Limited0SEBI

S

€334,71046,000 shares@ €7.2763

Equity Shares

SEBI:07f81794227b1fd6320997d355a0cfb9955d637c·16 Aug 2022

Ideal exit: 13 May 2023 (T+270)

Executives●SaleSSyngene International Limited0SEBI

S

€339,10846,000 shares@ €7.3719

Equity Shares

SEBI:3f92f3e742c6c96c75c931b4c8505aff6ed0d3be·16 Aug 2022

Executives●SaleSSyngene International Limited0SEBI

S

€42,7716,000 shares@ €7.1285

Equity Shares

SEBI:7ff053087042b241d06f69d4682def54fc2888be·23 Dec 2021

Executives●PurchaseSSyngene International Limited0SEBI

S

€691,24496,036 shares@ €7.1978

Equity Shares

SEBI:c28462f0379d22132e91d3069d2c76b0b2f8bbfb·18 Nov 2021

Ideal exit: 15 Aug 2022 (T+270)

15 of 15 declarations